Label-Free and Homogeneous Sensing Platform with Template-Independent Cascade Amplification Strategy for Genome-Wide 5-Hydroxymethylcytosine Analysis
Analytical Chemistry · 02.06.2026 · 98 (21) · 15803-15810
DOI: 10.1021/acs.analchem.6c01770 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 15.05.2026. Verfasst von Sai Jing und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Molecular Engineering, Qingdao University of Science and Technology, Qingdao 266042, China. Hauptthemen laut MEDLINE: 5-Methylcytosine, Nucleic Acid Amplification Techniques. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Young Talent of Lifting engineering for Science and Technology in Shandong, China.
Abstract (Originalsprache)
5-Hydroxymethylcytosine (5hmC) is an important epigenetic mark in DNA, and its dysregulation is closely associated with cancer and neurodegenerative diseases. However, due to the structural similarity with 5-methylcytosine (5mC), existing detection techniques for distinguishing 5hmC from 5mC often involve either cumbersome separation steps or DNA-damaging treatments. In this work, we developed a template-independent cascade amplification-based sensing platform for homogeneous, label-free, and genome-wide detection of 5hmC. The platform integrated terminal transferase (TdT)-mediated template-independent nucleic acid amplification with APE1-driven cyclic cleavage for cascaded signal enhancement. The assay required only a signal probe containing an apurinic/apyrimidinic (AP) site, with no need for separation steps. This method achieved a detection limit as low as 6.34 × 10-17 M and could specifically identify as low as 0.099% 5hmC in the presence of 5mC and cytosine (C). At the cellular level, the assay exhibited a sensitivity of 2.33 × 10-5 ng/μL for U-118MG cells and successfully distinguished different tumor cell lines and cancerous/normal tissues. Our results were consistent with those obtained by commercial ELISA kits, but the cost was reduced by 3.6-fold. Moreover, this method can accurately distinguish cancer patients from healthy individuals (P < 0.001), with an area under the receiver operating characteristic curve (AUC) of 0.993, holding potential applications in tumor liquid biopsy and epigenetic marker screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Molecular Engineering, Qingdao University of Science and Technology, Qingdao 266042, China.
- Weifang People's Hospital, Shandong Second Medical University, Weifang 261000, China.
ORCID-Profile: Chen-Chen Li, Xiliang Luo
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Young Talent of Lifting engineering for Science and Technology in Shandong, China
Zitieren
APA
Jing, S., Xing, T., Liu, S., Zhang, M., He, M., Li, C. C., & Luo, X. (2026). Label-Free and Homogeneous Sensing Platform with Template-Independent Cascade Amplification Strategy for Genome-Wide 5-Hydroxymethylcytosine Analysis. Analytical Chemistry, 98(21), 15803-15810. https://doi.org/10.1021/acs.analchem.6c01770
Vancouver
Jing S, Xing T, Liu S, Zhang M, He M, Li CC, et al. Label-Free and Homogeneous Sensing Platform with Template-Independent Cascade Amplification Strategy for Genome-Wide 5-Hydroxymethylcytosine Analysis. Analytical Chemistry. 2026;98(21):15803-15810. doi:10.1021/acs.analchem.6c01770
BibTeX
@article{Jing2026,
author = {Jing, Sai and Xing, Tianyun and Liu, Shixin and Zhang, Mingyue and He, Maotao and Li, Chen-Chen and Luo, Xiliang},
title = {Label-Free and Homogeneous Sensing Platform with Template-Independent Cascade Amplification Strategy for Genome-Wide 5-Hydroxymethylcytosine Analysis},
journal = {Analytical Chemistry},
year = {2026},
volume = {98},
number = {21},
pages = {15803--15810},
doi = {10.1021/acs.analchem.6c01770}
}
EUVIMED